No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic disorder worldwide, reaching prevalence up to 90 % in obese patients with type 2 diabetes (T2D), and representing an independent risk factor for cardiovascular mortality. Furthermore, the coexistence of T2D and NAFLD le...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Med
Auteurs principaux: Barchetta, Ilaria, Del Ben, Maria, Angelico, Francesco, Di Martino, Michele, Fraioli, Antonio, La Torre, Giuseppe, Saulle, Rosella, Perri, Ludovica, Morini, Sergio, Tiberti, Claudio, Bertoccini, Laura, Cimini, Flavia Agata, Panimolle, Francesca, Catalano, Carlo, Baroni, Marco Giorgio, Cavallo, Maria Gisella
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4926287/
https://ncbi.nlm.nih.gov/pubmed/27353492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-016-0638-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires